Market-Moving News for September 12th
Market-Moving News for September 12th
CSBR: 59% | Champions Oncology shares are trading higher after the company reported better-than-expected Q1 financial results. Also, Craig-Hallum upgraded the stock from Hold to Buy and maintained its $6 price target.
CSBR: 59% | champions oncology的股票上漲，該公司報告的Q1財務業績超出預期。此外，Craig-Hallum將股票的持有評級上調爲買入，並維持其6美元的目標價。
NTGR: 31% | NETGEAR shares are trading higher after the company disclosed a settlement agreement with TP-Link Systems and raised its Q3 revenue guidance.
NTGR: 31% | netgear的股票上漲，該公司披露了與TP-Link Systems的和解協議，並提高了其Q3營業收入指引。
FULC: -74% | Fulcrum Therapeutics' Phase 3 REACH Trial Of Losmapimod In Facioscapulohumeral Muscular Dystrophy Did Not Achieve Its Primary Endpoint Of Change From Baseline In Relative Surface Area With Losmapimod Compared To Placebo. In Addition, Secondary Endpoints Did Not Achieve Nominal Statistical Significance
FULC: -74% | fulcrum therapeutics旗下的腱科學肌肉萎縮症的3期REACH試驗並未達到其相對錶面積與安慰劑相比變化的主要終點。此外，次要終點未達到名義統計學上的顯著性。
